TP53 and neoplasm: METTL1 increases the chemosensitivity of CC cells to cisplatin by regulating the miR‐149‐3p/S100A4/p53 axis, thereby enhancing apoptosis and inhibiting tumour cell survival under chemotherapeutic stress.74